检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:努尔艾合麦提·加马力 祖丽胡玛·色依提 单雪峰[1]
机构地区:[1]新疆医科大学第一附属医院小儿心胸外科,新疆 乌鲁木齐
出 处:《临床医学进展》2023年第3期3173-3177,共5页Advances in Clinical Medicine
摘 要:中性粒淋巴细胞比值(NLR)作为一种简便,可靠,容易获取的复合性指标逐渐在心血管,肿瘤学科领域上被学者关注。越来越多的研究证实NLR与多种心血管疾病发病,发展及其预后相关。本文主要综述NLR与冠状动脉粥样硬性心脏病,高血压,心律失常,心力衰竭,心脏瓣膜病病因及预后的关系,以便临床工作者对此类高危险患者早识别早干预,预防患者并发症,改善患者预后。Neutrophil lymphocyte ratio (NLR) is gaining attention as a simple, reliable, and easily accessible composite index in the field of cardiovascular and oncology. An increasing number of studies have confirmed the association of NLR with the pathogenesis, development and prognosis of various car-diovascular diseases. This article reviews the relationship between NLR and the etiology and prog-nosis of atherosclerotic heart disease, hypertension, arrhythmias, heart failure, and heart valve disease, in order to facilitate early identification and intervention of such high-risk patients, pre-vent complications, and improve their prognosis by clinical workers.
关 键 词:中性粒与淋巴细胞比值 心血管疾病 预后 综述
分 类 号:R54[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.117